+1 (202) 780-3397
2023: Volume 7, Issue 2
Commentary P.1-2
Smart pills: The future of pharmaceutical technology.
Author(s): Suiyi Gladia
DOI: 10.35841/aapccs-7.2.136
Opinion Article P.1-2
Pharmacophore-based molecular docking for drug discovery.
Author(s): Jiahui Giangreco
DOI: 10.35841/aapccs-7.2.137
Perspective P.1-2
Enhancing drug safety with therapeutic index monitoring.
Author(s): Zhang Zhao
DOI: 10.35841/aapccs-7.2.138
Rapid Communication P.1-2
Combining docking and molecular dynamics for accurate binding free energy estimation
Author(s): Jeong Min
DOI: 10.35841/aapccs-7.2.139
Short Communication P.1-2
Half-Life and drug interactions: Implications for polypharmacy and adverse reactions
Author(s): Ruiz Hensler
DOI: 10.35841/aapccs-7.2.140
Commentary P.1-2
Investigating drug-induced toxicity: Chemical mechanisms and mitigation strategies
Author(s): Kevin Liu
DOI: 10.35841/aapccs-7.2.141
Opinion Article P.1-2
The chemistry of psychostimulants and neurotransmitter transporters
Author(s): Ellen Paul
DOI: 10.35841/aapccs-7.2.142
Perspective P.1-2
The importance of biotransformation in drug metabolism
Author(s): Lorena Mingwan
DOI: 10.35841/aapccs-7.2.143
Rapid Communication P.1-2
Maximizing efficiency with capsule banding technology.
Author(s): Sina Aparna
DOI: 10.35841/aapccs-7.2.144
Short Communication P.1-2
The importance of good manufacturing practices in pharmaceutical regulatory compliance
Author(s): Jacques McCarthy
DOI: 10.35841/aapccs-7.2.145